Objective: It was hypothesized that psychophysiological insomniacs, who have been shown to have elevated heart rate, body temperature, and whole body metabolic rate, would also have increased low frequency and decreased high frequency power in the spectral analysis of their heart period data. Method: Groups of 12 objectively defined insomniacs and age-, sex-, and weight-matched controls with normal sleep were evaluated on sleep and EKG measures over a 36-hour sleep laboratory stay. Results: Heart period was decreased (ie, heart rate was increased) and its SD was decreased in all stages of sleep in the insomniacs compared with the controls. Spectral analysis revealed significantly increased low frequency power and decreased high frequency power in insomniacs compared with controls across all stages of sleep. Conclusions: Because increased low frequency spectral power is an indicator of increased sympathetic nervous system activity, these data imply that chronic insomniacs could be at increased risk for the development of disorders, such as coronary artery disease, that are related to increased sympathetic nervous system activity. Key words: insomnia, heart rate, heart rate variability, spectral analysis, sympathetic nervous system, parasympathetic nervous system, sleep disorders, sleep. EMG = electromyogram; EEG = electroencephalogram; MSLT = Multiple Sleep Latency Test; Ss = subjects; SaO 2 = oxygen saturation; AD = analog to digital; REM = rapid eye movements; SWS = slow wave sleep; LFP = low frequency power; HFP = high frequency power.
INTRODUCTION
Several studies have shown that patients with chronic psychophysiological insomnia show evidence of elevated physiological activity during their sleep. For example, Monroe (1) reported a significant increase in rectal temperature, basal skin resistance, and phasic vasoconstrictions 30 minutes before and during sleep in insomniacs compared with normal sleepers. It was also reported that insomniacs had increased heart rate, but this difference was not statistically significant. In other studies, sleep-onset insomniacs have been shown to have increased heart rate (2, 3), increased frontalis EMG (4), increased finger temperature, increased 24-hour metabolic rate (5) , and more /3 and less a frequencies in their EEG (6, 7) before sleep onset. Poor sleepers have increased secretion of corticosteroids and adrenaline (8, 9) compared with good sleepers in most, but not all, studies (10) .
Another line of research has examined the daytime functioning of insomniacs to determine the existence of subjectively reported deficits in performance, mood, and alertness. The cumulative partial sleep deprivation that should arise from chronic insomnia would be expected to produce daytime sleepiness or increased susceptibility to acute sleep loss in insomniacs, but studies have consistently found that insomniacs are not sleepier than normal controls on MSLT (11) (12) (13) or after sleep loss (14) and may actually have longer MSLT latencies (5, 15, 16) . Studies have found that insomniacs made more errors on a line tracing task (17) , produced fewer responses in a word category test (11) , and performed worse on the Romberg (balance) test (18) . These results may be interpreted as insomniacs producing worse performance on tests where too much arousal reduces steadiness or blocks higher order associates. However, studies comparing daytime performance in insomniacs with normal controls generally have not found differences on tests that are sensitive to sleep loss (13, 18) . On the basis of the results of these studies and patient reports that they are fatigued or "washed out" during the day, investigators have hypothesized that standard sleep and sleep loss tests are confounded in that they "simultaneously measure sleep need and hyperarousal, which is interfering with sleep onset" (Ref. 15, p. 59 ). This concept is supported by studies reporting significant negative correlations between total sleep at night and MSLT values the next day (13, 15, 17) .
Increased heart rate, body temperature, metabolic rate, and secretion of corticosteroids and adrenaline are all indicators of increased sympathetic nervous system activity. Spectral analysis techniques also have been used to link changes in heart rate to underlying central nervous system activity. Spectral analysis has suggested that power in specific frequency bands can be related to parasympathetic and sympathetic nervous system activity. Specifically, relative power in high frequency areas, usually from 0.15 to 0.5 Hz, has been used to infer parasympathetic nervous system activity. Evidence has been published that the peak in the lower frequency component is in the range of .09 to .11 with a SD of about .02 (19) . To include both the peak and surrounding area, a range of lower frequencies from 0.05 to 0.15 Hz typically has been related to a combination of parasympathetic and sympathetic influences (20) (21) (22) . Because the lower frequency power is a combination of sympathetic and parasympathetic effects, investigators frequently infer sympathetic nervous system activity from the ratio of low (parasympathetic and sympathetic) to high (predominantly sympathetic) power so that parasympathetic power to some extent cancels out of the ratio (21, 23, 24) , leaving a better indicator of sympathetic activity. Jaffe et al. (20) , in a study of heart rate changes as a function of posture change, found this "sympathetic index" correlated to heart rate changes. Studies of children (25) and adults (26) , using spectral analysis techniques, consistently have found increased parasympathetic activity during NREM sleep, as measured by high frequency heart rate variability and increased sympathetic activity during REM sleep, as typically measured by the ratio of lower to higher frequency heart rate variability. These findings agree well with earlier studies of heart rate and direct measures of nerve activity (27, 28) .
In the current study, heart rate variability was examined in psychophysiological insomniacs and matched normals with the hypothesis that, throughout the night, insomniacs would display increased heart rate (as indexed throughout this study as shorter periods between heart beats), decreased variability,
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and increased low frequency spectral power characteristic of increased sympathetic nervous system activity.
METHOD Subjects
Ss were required to be healthy, 18-to 50-year-old men and women. Potential Ss were solicited from sleep center referrals and from advertisements in the local newspapers for participants in sleep research.
Insomniacs. Individuals completing a screening questionnaire indicating a) that they had a sleep problem; b) that it took them 45 minutes or more to fall asleep at least 4 nights each week or that they were awake for 60 minutes or more each night after falling asleep for at least 4 nights each week; and c) that this condition had existed for at least 1 year were considered for participation in the study (see common exclusions below).
Normals. Normals were required to indicate normal sleep on their screening questionnaire. They were also required to report a sleep latency of less than 30 minutes and less than 30 minutes of wake time during the night. Normal subjects additionally were required to match a qualified insomniac by sex, age (within 5 years), weight (within 25 pounds), and general time in bed characteristics.
Exclusions. Potential normal or insomniac subjects who indicated excessive caffeine consumption (more than 250 mg of caffeine per day), who were using psychoactive medication or drugs, or who had completed a drug or alcohol abuse program within the previous year were excluded. Ss with a history of depression or psychiatric hospitalization within the previous year were excluded. Potential Ss who had histories strongly suggestive of circadian desynchrony (eg, shift workers), sleep apnea, or periodic leg movements were excluded. Of selected subjects, two were taking medication when initially contacted. One subject had taken Synthroid (Boots Pharmaceuticals, Inc., Lincolnshire, IL) for several years for an underactive thyroid and was continued on standard medication throughout the study. One subject had taken a benzodiazepine for sleep approximately 3 nights per week until applying for the study. This subject was removed from medication for 2 weeks before participation. Two subjects had seen a psychiatrist in their lifetime. Except for the subject removed from the benzodiazepine, no subject had used psychoactive medication for the 3 months before the study.
Subjects meeting the above criteria were invited to participate in the study after completing an informed consent and 2 hours of acclimatization to the laboratory with practice on computer tests and questionnaires to be used in the study.
Design. After practice, subjects were scheduled to spend 2 nights and the intervening day in the laboratory. On both nights, a standard clinical polysomnogram, including two eye channels, central and occipital EEG channels, chin and leg EMG channels, EKG, airflow, and chest movements, was performed (29, 30) . On the first night, SaO 2 was also recorded. On the second night, metabolic measures and a time code were recorded instead of SaO 2 .
All subjects were assigned their own room for the course of the study. Each room contained a standard hospital bed and furniture, including a desk with an Apple IIGS computer. Subjects participated in the study in groups of one to two individuals. Subjects completed tests and questionnaires at their individual computer workstation in their room under technician observation via video monitors. Meals and breaks were scheduled in another area of the laboratory, which was also within the observation area of the technician. Ss performed computer tests, completed an MMPI and a sleep history, and were fed the same daily menu of food prepared at the laboratory during the day. Caffeinated beverages were not available. Subjects usually did not leave the laboratory during this day and did not engage in any activity more vigorous than walking to the bathroom. After the second night in the laboratory, subjects completed some brief computer tests and were allowed to leave.
Subject Groups. To qualify for the study as an insomniac, individuals were required to report insomnia as described earlier and to have EEG sleep latencies greater than 30 minutes on both laboratory nights or to have a sleep efficiency of less than 85% on both nights. Subjects with an apnea/hypopnea index greater than 10 or a periodic leg movement arousal index greater than 10 were disqualified.
To qualify for the study as a normal, individuals were required to report normal sleep as described earlier and to have EEG sleep latencies of less than 30 minutes on both laboratory nights and to have a sleep efficiency greater than 90% on both nights (and not to have sleep apnea or leg movements as defined above). Twelve normal participants met the above requirements and could be matched with one of the insomniacs on the basis of age, weight, and sex. Therefore, the results reported in this study reflect the data obtained from two groups of 12 age-, sex-, and weight-matched individuals (normals and insomniacs).
EKG Data Collection. Beginning 30 minutes before lights out on the second night in the laboratory, EKG data were digitized by a National Instruments NB-MIO-16 AD Board sampling at a rate of 500 samples per second. A time code was digitized by a second channel on the AD board and also printed out on the polygraph paper to allow epoch by epoch matching of digitized EKG with sleep stages and events. The EKG and time code data were collected by Lab View 3.0 software running on a Macintosh II computer and stored to optical disk. Data collection was continuous throughout the sleep period. After awakening at their normal time of arising in the morning, Ss were asked to stand up for a final 10-minute EKG recording period.
After collection, the EKG and time data were visualized and checked for artifacts with the Labview software and output to a separate peak detection program used to construct the tachogram and associated time code. The tachogram data was again examined for artifacts and converted for input into the BMDP Tl (Spectral Analysis) Program. Five-minute sequential time periods were identified from the sleep record with the following constraints: a) Data from the presleep baseline waking period and postsleep standing data were blocked and separated from the sleep period data, b) Fiveminute blocks were chosen, whenever possible, to contain a single sleep stage; this included, on occasion, shortening or lengthening a block by up to 1 minute or skipping 1 to 2 minutes of recording, c) When a block contained a mixture of sleep stages, the "lightest" stage was assigned (wake < stage 1 < stage 2 < REM < SWS). Whenever possible stages 2 and REM were not included in the same block. In practice, all subjects had many pure blocks of stage wake, stage 2, and REM and about 100 total blocks per night. Four Insomnia patients and four Normals did not have sufficient slow wave sleep for any blocks to be labeled as SWS.
Analyses. Data were compared by sleep stage of block as defined above. Two spectral variability measures were examined: a) LFP was defined as the. total spectral power in the 0.05 to 0.15 Hz frequency band divided by the total spectral power in the 0.15 to 0.50 Hz frequency band; b) HFP was defined as the total spectral power in the 0.15 to 0.50 Hz frequency band divided by the total spectral power (0.0-0.50 Hz). Linear trends were removed from the data using the Detrend option of the BMDP IT program, and the spectral analysis was performed using the Rectangular option for the shape of the periodogram weighting function (31). The simple mean and SD for heart period were also calculated for the 5-minute blocks defined above. All reported results in the text will refer to statistically significant differences (p < .05) except where noted otherwise. In analysis of variance in which interaction F values were nonsignificant, the interaction variance was pooled with the error variance to test main effects. Where indicated by significant F values from analysis of variance, pairwise comparisons, using degrees of freedom defined by the Huynh-Feldt correction, were made using the Newman-Keuls procedure at the p < .05 level.
Subjects were matched by age, weight, and sex specifically to allow within subject pair comparisons. As such, paired ( tests or repeated measures analyses of variance were performed on the data.
RESULTS
Demographic data from the 12 pairs of normals and insomniacs can be found in Table 1 . The groups did not differ in age or weight. As expected by selection criteria, insomniacs reported significantly longer sleep latencies and shorter total sleep per night on their subjective sleep screening forms. Results from the performance tests will not be reported in this paper.
Objective and subjective sleep data from the two groups for the EKG data collection night are presented in Table 2 . It can be seen from Table 2 that sleep was significantly different in the two groups based on the inclusion criteria. Total sleep time was significantly shorter and wake time during the night was greater in the insomniacs. Decreased total sleep time in the insomniac group came primarily from decreased stage 2, although the 1% decrease in stage 2 was significant only at the p < O.I level. The insomniacs also gave subjective reports of significantly longer latencies and decreased total sleep time as compared with the normals on the EKG data collection night.
Heart Period and Heart Period SD Analyses The interval between heart beats (in ms) and the SD of the intervals for the 5-minute periods selected for spectral analysis were analyzed for comparison purposes. Analysis of variance with a term for Group (Insomniac vs. Normal) and Sleep Stage (stage wake, stage 1, stage 2, and REM) was performed. The data are presented in Figures I and 2 . Analysis of variance indicated that the interaction F value for Group by Stage was not significant for either the intervals or for the SD of the intervals (F(3,33) = 0.63, NS and F(3,33) = 1.87, NS). There was a significant main effect for Group for both beat-to-beat interval (F(l,44) = 44.67, p < .001) and the interval SD (F(l,47) = 56.16, p < .001). The intervals were reliably longer (ie, heart rate was lower) and the variability was greater in the normal Ss, compared with the insomniacs. There was a significant main effect for Sleep Stage for both beat-to-beat interval (F(l,65) = 9.13, p < .001) and the interval SD (/ 7 (l,69) = 30.57, p < .001). Newman-Keuls pairwise comparisons indicated that the interval between beats was shorter during wake and REM, which did not differ from each other, than in stage I and stage 2, which also did not differ from each other. Variability was least in stage 2 and increased significantly with each stage from stage 2 to REM to stage 1 to wake.
Only eight of the Insomnia Ss and eight of the Normal Ss had sufficient SWS for any 5-minute period to be classified as SWS. Of these Ss, only four subject pairs could be formed. A t test for interval between beats revealed f 3 = 4.515, p = .02 (mean values of 0.84 vs. 1.095 for insomniacs vs. normals), and the t test for variability showed t 3 = .095, NS (mean values of 0.048 vs. 0.067 for insomniacs Vs normals). Heart Period Spectral Analysis Data Examination of the low frequency power ratio data revealed that these data were nonnormally distributed. A log transformation (of the data plus 1), therefore, was used to normalize the data. Figures 3 and 4 present mean LFP and HFP ratios from stage 1, stage 2, REM, and wake during the night for Insomniacs and Normals. Analysis of variance indicated that the interaction F value for Group by Stage was not significant for either LFP or HFP analyses (F(3,33) = 1.407, NS and F(3,33) = 1.766, NS). There was a significant main effect for Group for both LFP (F(l,32) = 12.93, p < .001) and HFP (F(l,44) = 12.21, p < .001). These results, as seen in the figures, indicated that LFP was increased and HFP was decreased in insomniacs, compared with normals across all sleep stages. There was a significant main effect for Stage for both LFP (F(l,32) = 12.62, p < .001) and HFP (F(l,44) = 12.21, p < .001). Pairwise comparisons showed that low-frequency ratio power was significantly greater when subjects were awake than when they were in stage I or REM and that stage 1 and REM values, which did not differ, were greater than those for stage 2. In a similar manner, pairwise comparisons showed that high-frequency ratio power was significantly less when subjects were awake than when they were in stage 1 or REM, and that stage 1 and REM values, which did not differ, were less than those for stage 2.
Only eight of the Insomnia Ss and eight of the Normal Ss had sufficient SWS for any 5-minute period to be. classified as SWS. Of these Ss, only four subject pairs could be formed. A t test for LFP revealed t 3 = 2.78, p < .07 (mean values of 1.53 vs. 65 for insomniacs vs. normals), and the t test for HFP showed t 3 = 3.69, p < .05 (mean values of 0.289 vs. 0.598 for insomniacs vs. normals).
DISCUSSION
Several previous studies have shown increased heart rate in insomniacs as compared with normals during the night. Monroe (1) reported a nonsignificant 3.9 bpm increase in insomniacs, Stepanski (3) reported a significant 4.4 bpm increase in insomniacs, and Haynes (2) reported a significant 4.6 bpm increase in insomniacs compared with normal sleepers. These reported differences agree well with the data from the present groups where the overall mean difference in heart period translated to a heart rate difference of 6.9 bpm. In general, the previous studies, with the exception of the Haynes study, which reported EKG only from wake periods, could be criticized because a comparison of nocturnal heart rates would be influenced by the sleep stage composition of the nights; that is, heart rate is higher when Ss are awake, and insomniacs, who are awake for longer periods of time, therefore, would be expected to have higher average heart rates solely on basis of increased wake time. The present study, which has compared heart periods within matched EEG time segments, provides similar results with the sleep stage controlled. It is also unlikely that the heart period differences are driven by the microstructure of sleep, because insomnia and normal groups had similar brief EEG arousal indices in the current study.
In the current study, traditional heart period mean and SD values were calculated from the same time intervals that were used in the spectral analysis to give a better idea of the relative sensitivity of the traditional and spectral measures. It is, therefore, notable that significance levels for all of the reported variables are similar; that is, if one were to choose (22) 2346 (133) 0748 (132) 22 (14) 18 (21) heart period, heart period SD, LFP, or HFP, one would come to similar conclusions about differences between stages and between insomniacs and normals. Many studies over several years have reported consistent enough differences in heart rate as a function of sleep stage that heart rate has even been proposed as a means of determining sleep stage (32) . Therefore, the reported sleep stage differences are expected.
For spectral analysis parameters, recently we have reported sleep stage differences between wake, stage 1, stage 2, and SWS in both LFP and HFP in a group of normal sleepers (33) . The current spectral analysis data reflect similar sleep stagerelated changes.
None of these differences between the insomniacs or normals could be based on age, sex, or weight, because subjects were matched carefully on those variables. In addition, the differences could not be based on immediate activities or diet because subjects remained in the laboratory over the 36-hour data collection period, including 24 hours before the collection of the data reported here, and were fed the same meals.
As an entity, insomnia is infrequently viewed as a significant medical problem. However, if insomnia is associated with chronic sympathetic hyperactivity, long-term consequences of the sympathetic activation associated with the insomnia may exist. Many risk factors for coronary heart disease are related to increased sympathetic activity. For example, hypertension, elevated plasma insulin (34) and its related decrease in HDL cholesterol, increase in triglyceride and cholesterol (35) , increased hematocrit (36), decreased plasma volume (37), increased plasma thromboglobulin (38) , increased plasma angiotensin (39) , and increased cardiac arrhythmias (40, 41) are all signs of increased SNS and decreased PNS tone. All of these factors predispose to coronary disease. It remains to be seen whether any or all of these factors may be abnormal in patients with chronic insomnia. Furthermore, sleep itself is being increasingly identified as a source of cardiac risk (42) . It has been known for some time that there is an increased risk of mortality associated with short sleep lengths. In the Alameda County study (43) , the age-adjusted mortality rate for men who typically slept less than 6 hours per night and often had trouble sleeping was 2.5 times the rate for 7 to 8 hour sleepers with no sleep problem. Men who died from coronary heart disease were more likely to have had reported sleep lengths of less than 4 hours than longer sleep lengths (44), although similar findings were reported for other diseases such as cancer.
Fatigue was a predictor of myocardial infarction even after adjustment for the effects of blood pressure, blood sugar, antihypertensives, smoking, and age (45) . In patients with documented myocardial infarction, 39% reported preceding insomnia (46) . Elderly individuals who reported insomnia also reported both angina pectoris and cardiac arrhythmia (47) more than twice as often as individuals without insomnia. If insomnia is a sympathetic disorder predisposing to increased cardiac risk, there could be a direct pathophysiological explanation of the increased mortality in insomniacs and an implication that insomnia, like hypertension, could be a silent and treatable indicator of cardiovascular disease. Treatments for insomnia, such as relaxation, exercise training, and some medications, have in common a shift away from sympathetic nervous system dominance and toward parasympathetic system activation. As such, these treatments may provide long-term benefits over and above short-term improvement in reported sleep quality. If additional examination of patients with chronic insomnia provides evidence of links to coronary artery disease, more rigorous or prolonged treatment of patients by such methods may be indicated.
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